HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.

Abstract
Tautomycin isolated from Streptomyces spiroverticillatus is an inhibitor of protein phosphatases 1 and 2A. Tautomycin induced hyperphosphorylation of cytokeratin peptides in human keratinocytes (PHK 16-I cells) 30 times less strongly than did okadaic acid. Repeated applications of tautomycin (30 micrograms, 40 nmol/application) did not induce tumor promotion in a two-stage carcinogenesis experiment on mouse skin initiated with 7,12-dimethylbenz[a]anthracene, whereas okadaic acid (1 microgram, 1.2 nmol/application) as a control induced tumor promotion strongly. As for mucosa of rat glandular stomach, tautomycin induced ornithine decarboxylase 4 h after intubation into the stomach. The tumor-promoting activity of tautomycin was next studied in the glandular stomach initiated with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Administration of tautomycin in the diet (1 mg rat-1 day-1), from week 9 to week 52 of the experiment, inhibited rather than enhanced tumor development in the glandular stomach initiated with MNNG. The percentages of tumor-bearing rats of the groups treated with MNNG plus tautomycin, MNNG alone, and tautomycin alone were 20.0%, 40.6%, and 0% respectively in week 52. The reason for the absence of tumor-promoting activity of tautomycin was studied in relation to tumor necrosis factor alpha (TNF alpha), an endogenous tumor promoter. We found that tautomycin neither enhanced TNF alpha mRNA expression in mouse skin nor induced TNF alpha release in a human stomach cancer cell line (KATO III cells), whereas okadaic acid did both. These results indicate that not all inhibitors of protein phosphatases are tumor promoters, and suggest that tumor promotion of the okadaic acid class of compounds is mediated by TNF alpha.
AuthorsM Suganuma, S Okabe, E Sueoka, R Nishiwaki, A Komori, N Uda, K Isono, H Fujiki
JournalJournal of cancer research and clinical oncology (J Cancer Res Clin Oncol) Vol. 121 Issue 9-10 Pg. 621-7 ( 1995) ISSN: 0171-5216 [Print] GERMANY
PMID7559747 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifungal Agents
  • Carcinogens
  • Enzyme Inhibitors
  • Ethers, Cyclic
  • Pyrans
  • Spiro Compounds
  • Tumor Necrosis Factor-alpha
  • tautomycin
  • Okadaic Acid
  • Keratins
  • Phosphoprotein Phosphatases
  • Ornithine Decarboxylase
Topics
  • Animals
  • Antifungal Agents (pharmacology)
  • Carcinogens (pharmacology)
  • Enzyme Induction (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Ethers, Cyclic (pharmacology)
  • Female
  • Gene Expression (drug effects)
  • Humans
  • Keratins (metabolism)
  • Male
  • Mice
  • Okadaic Acid
  • Ornithine Decarboxylase (biosynthesis)
  • Phosphoprotein Phosphatases (antagonists & inhibitors)
  • Phosphorylation
  • Pyrans
  • Rats
  • Rats, Inbred F344
  • Rats, Sprague-Dawley
  • Spiro Compounds
  • Stomach Neoplasms (chemically induced)
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: